P60.11 TCR Repertoire Predicts Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy from NADIM Trial

التفاصيل البيبلوغرافية
العنوان: P60.11 TCR Repertoire Predicts Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy from NADIM Trial
المؤلفون: Santiago Viteri, G. López Vivanco, M. Jove, J. Casal, M. Majem Tarruella, R. Bernabe Caro, Alex Martinez-Marti, Belén Sierra-Rodero, R. Laza Briviesca, Nuria Viñolas, J. De Castro Campeño, Alberto Cruz-Bermúdez, A. Insa, M. Casarrubios, M.R. Garcia Campelo, M. Provencio, F. Franco, M. Cobo Dols, B. Massuti, Manuel Domine, E. Del Barco, Ernest Nadal, Delvys Rodriguez-Abreu, Isidoro Barneto
المصدر: Journal of Thoracic Oncology. 16:S545-S546
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Chemoimmunotherapy, Internal medicine, medicine, Pathological response, Tcr repertoire, business
تدمد: 1556-0864
DOI: 10.1016/j.jtho.2021.01.970
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::678df0f056f13bfa649d6024429304f4
https://doi.org/10.1016/j.jtho.2021.01.970
Rights: OPEN
رقم الانضمام: edsair.doi...........678df0f056f13bfa649d6024429304f4
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2021.01.970